FindTrial
Sign In

Prognostic Significance of TREM2-positive Tumor-Associated Macrophages in Patients with Prostate Cancer

Prognostic Significance of TREM2-positive Tumor-Associated Macrophages in Patients with Prostate Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108373
Enrollment
Unknown
Registered
2025-08-28
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Interventions

Case series:NA

Sponsors

Sun Yat-sen Memorial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The inclusion criteria for the study cases are as follows: Patients who underwent radical surgical resection with postoperative pathological confirmation. No preoperative radiotherapy or chemotherapy.

Exclusion criteria

Exclusion criteria: The exclusion criteria are as follows: Patients with a follow-up period of less than 3 years; Paraffin-embedded tissue specimens with incomplete tissue structure.

Design outcomes

Primary

MeasureTime frame
PSA;Pathological results;Gleason score;Tumor stage;Adjuvant therapy;Biochemical recurrence;Tumor metastasis;—

Countries

China

Contacts

Public Contactwangbo

Sun Yat-sen Memorial Hospital

wangb43@mail.sysu.edu.cn+86 158 2024 3195

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026